-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Cartesian Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2014 to 2023.
- Cartesian Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$17.6M, a 34.5% decline year-over-year.
- Cartesian Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$53.5M, a 8.68% increase year-over-year.
- Cartesian Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$86.4M, a 694% decline from 2022.
- Cartesian Therapeutics, Inc. annual Operating Income (Loss) for 2022 was $14.5M.
- Cartesian Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$4.6M, a 91.9% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)